Making a stair pattern. Has pulled back and its at the point it needs to make the up move.

Profile Get Profile for:




Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court
Suite 200
La Jolla, CA 92037
United States - Map
Phone: 858-875-8600
Fax: 858-875-8650
Web Site: http://www.orexigen.com

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Drug Manufacturers - Other
Full Time Employees: 47


BUSINESS SUMMARY
Orexigen Therapeutics, Inc., a biopharmaceutical company, focusing on the development of pharmaceutical product candidates for the treatment of obesity. The company’s lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II clinical development. It selected these two product candidates for obesity based research regarding CNS regulation of appetite and energy expenditure, as well as mechanisms in the brain that reinforce unhealthy eating behaviors. Each of these product candidates is a combination of generic drugs that is screened for synergistic CNS activity. Orexigen Therapeutics was founded in 2002 and is headquartered in La Jolla, California.


TOP INSTITUTIONAL HOLDERS

Holder Shares % Out Value* Reported
FMR LLC 2,459,214 7.09 $6,418,548 31-Mar-09
OPPENHEIMER FUNDS, INC. 1,465,640 4.23 $3,825,320 31-Mar-09
FEDERATED INVESTORS, INC. 1,182,172 3.41 $3,085,468 31-Mar-09
Barclays Global Investors UK Holdings Ltd 958,129 2.76 $2,500,716 31-Mar-09
WASATCH ADVISORS INC 858,066 2.48 $2,239,552 31-Mar-09
PRINCIPAL FINANCIAL GROUP, INC. 832,700 2.40 $2,173,347 31-Mar-09
VANGUARD GROUP, INC. (THE) 673,323 1.94 $1,757,373 31-Mar-09
FRANKLIN RESOURCES, INC 600,710 1.73 $1,567,853 31-Mar-09
ADAGE CAPITAL PARTNERS GP, L.L.C. 588,901 1.70 $1,537,031 31-Mar-09
PUTNAM INVESTMENT MANAGEMENT, LLC 394,466 1.14 $1,029,556 31-Mar-09


TOP MUTUAL FUND HOLDERS

Holder Shares % Out Value* Reported
FEDERATED KAUFMANN FUND 1,000,000 2.89 $2,840,000 30-Apr-09
FIDELITY GROWTH COMPANY FUND 677,357 1.95 $2,411,390 31-May-09
OPPENHEIMER QUEST FOR VALUE FD-OPPENHEIMER QUEST OPPORTUNITY 484,880 1.40 $1,377,059 30-Apr-09
FRANKLIN STRATEGIC SERIES-FRANKLIN BIOTECHNOLOGY DISCOVE 476,754 1.38 $1,353,981 30-Apr-09
OPPENHEIMER BALANCED FUND 334,030 .96 $871,818 31-Mar-09
FIDELITY SELECT PORTFOLIOS - BIOTECHNOLOGY 317,199 .92 $1,129,228 31-May-09
ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND 315,294 .91 $1,122,446 31-May-09
ISHARES RUSSELL 2000 INDEX FD 246,798 .71 $878,600 31-May-09
PRINCIPAL SMALL CAP GROWTH FD 245,854 .71 $698,225 30-Apr-09
WASATCH SMALL CAP GROWTH FUND 225,795 .65 $589,324 31-Mar-09

__________________
"People are not remembered by how few times they fail, but how often they succeed."
- Thomas Edison

http://motorbicycling.com/
motorbicycles that get over 150 MPG. Stop by and learn how to beat the gas wars.....

The Green Revelotion has begun. Save the planet. Stop by our green energy site at:
http://www.nature2energy.com


Articles by Gwitt
http://www.triond.com/users/GWitt

Made a big move today. I was in this back in May when it was in $2-3 range. I just jumped back in on a pull-back. Tried to get in under $10 but took $10.20 as an entry point. See where it goes now.

__________________
fz4fun

-----------------------

It's only money----but try not to lose it, OK?